In the lung, IL-33 participates in the activation of most of the inflammatory processes in which ILC2s are involved (Figure 1); it does so by inducing the expression of IL-5 and IL-13, mainly in models of upper airway inflammation or helminth infection (53–55). Here, IL5 is linked to helminthiasis.